Source | Age at diagnosis(yr) | Tumor size (cm) | Stage | Kind of surgery | Lymph nodes metastasis | Chemotherapy | Radiotherapy | Endocrinotherapy | ER | PR |
---|---|---|---|---|---|---|---|---|---|---|
Present | 43 | 3 × 2 | T2N0M0 | MRM | 0/11 | TEC, 6 cycles | - | TAM | + | + |
case | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Xing Wang et al, | 61 | 2 × 2 | T1N0M0 | RM | 0/19 | CU, 4 cycles | - | TAM | + | + |
2007[5] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Xing Wang et al, | 42 | 3.5 × 3.5 | T2N0M0 | MRM | 0/24 | CMF, 6 cycles | Only internal | - | - | + |
2007[5] | Â | Â | Â | Â | Â | Â | Mammary area | Â | Â | Â |
Xing Wang et al, | 49 | 4 × 4 | T2N1M0 | MRM | 4/20 | CEF, 6 cycles | - | TAM | + | - |
2007[5] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Xing Wang et al, | 39 | 2.5 × 2.5 | T2N0M0 | MRM | 0/18 | CEF, 4 cycles | - | TAM | + | + |
2007[5] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Xing Wang et al, | 33 | 1.5 × 1.5 | T1N0M0 | MRM | 0/15 | - | - | - | - | - |
2007[5] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Xing Wang et al, | 49 | 5 × 4 | T2N1M0 | MRM | 3/10 | CEF, 6 cycles | - | TAM | - | + |
2007[5] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Rosso R et al, | 53 | / | T1N0M0 | MRM | / | - | - | / | / | / |
2000[4] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Rosso R et al, | 63 | / | T1N0M0 | / | / | - | - | / | / | / |
2000[4] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
B Baltalarli et al, | 52 | / | T2N0M0 | / | / | Anthracycline-based | External | AI | / | / |
2004[7] Kim EY et al, 2011[8] | 33 | / | T2N0M0 | MRM | / | chemotherapy, 4 cycles Adjuvant chemotherapy for 1 year* | Radiotherapy - | / | / | / |